OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Paracrine signals of the tumour niche control the growth of tumours, either directly or by modulation of an anti-tumour immune response. Several of these paracrine factors are produced as membrane-bound proteins and need to be released by limited proteolysis.
Members of the a disintegrin and metalloprotease (ADAM) family of transmembrane proteases are major mediators of cytokine and growth factor release. I will discuss the potential role of ADAM proteases in shaping a tumour permissive niche. I will provide evidence that within the tumour micro-environment the family member ADAM17 is a major promoter of primary tumour growth and metastasis through initiation of TNF-mediated necroptosis, the release of EGF receptor ligands and the induction of IL-6/GP130 trans-signalling. In this context I will discuss the controversial role of IL-6 family cytokines in the control of tumour growth. By using a novel mouse model of cell-autonomous IL-6/GP130 signalling, I will provide evidence that this might be linked to cell type-specific signalling of these cytokines. Based on our findings I will discuss potential novel therapeutic strategies.
